← Leaderboards
Dhiraj Yadav
University Of Pittsburgh At Pittsburgh
$8,018,338
Attributed
$16,397,499
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,397,499 · 7
By mechanism
U01$13,476,715 · 3
R01$2,325,010 · 2
U34$350,614 · 1
T32$245,160 · 1
Top collaborators
- Randall Brand10 shared
- Frederico G. S. Toledo7 shared
- David C Whitcomb7 shared
- Gregory A Cote6 shared
- Valerie L Durkalski5 shared
- Yogish C. Kudva2 shared
- Gavin E Arteel1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David C Whitcomb$21,073,858
- Debra Kaye Weiner$3,397,320
- Steven J Hughes$2,808,835
- Randall Brand$11,652,606
- Adam Slivka$3,034
Others in their field
Top investigators on “Acute Pancreatitis”
- Walter N Kernan · Yale University$42,197,025
- Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr$24,072,901
- David C Whitcomb · University Of Pittsburgh At Pittsburgh$16,218,176
- Richard D Schulick · Johns Hopkins University$13,077,395
- Rodger A. Liddle · Durham Va Medical Center$11,109,230
- Ashok K Saluja · Beth Israel Deaconess Medical Center$10,724,855
Research focus
Acute PancreatitisChronic PancreatitisRecurrencePancreatitisCohortSamplingDiabetes MellitusUniversitiesDesignProgramsResourcesSuccessEnsureEpidemiologyPancreatic DiseasesMalignant Neoplasm Of PancreasCollaborationsFollow-UpPancreasPainClinical ResearchAreaBiologicalClinical Infrastructure
Grant awards (36)
UPMC Clinical Center for the Study of Chronic Pancreatitis and Diabetes$556,500
U01 · FY2025 · DK · contact PI
UPMC Clinical Center for the Study of Diabetes after Acute Pancreatitis$508,800
U01 · FY2025 · DK · contact PI
Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial$317,984
R01 · FY2025 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$457,915
U01 · FY2024 · DK · contact PI
Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial$333,445
R01 · FY2024 · DK
UPMC Clinical Center for the Study of Diabetes After Acute Pancreatitis$278,099
U01 · FY2024 · DK · contact PI
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center$112,819
U01 · FY2024 · DK · contact PI
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$476,995
U01 · FY2023 · DK · contact PI
UPMC Clinical Center for the Study of Diabetes After Acute Pancreatitis$278,099
U01 · FY2023 · DK · contact PI
Consortium for the study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Consortium â Pittsburgh Clinical Center$134,997
U01 · FY2023 · DK · contact PI
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$476,995
U01 · FY2022 · DK · contact PI
UPMC Clinical Center for the Study of Diabetes After Acute Pancreatitis$278,099
U01 · FY2022 · DK · contact PI
Digestive Diseases Training Program$245,160
T32 · FY2022 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$100,000
U01 · FY2022 · DK · contact PI
SpHincterotomy for Acute Recurrent Pancreatitis$1
U01 · FY2022 · DK
SpHincterotomy for Acute Recurrent Pancreatitis$1,960,097
U01 · FY2021 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$469,495
U01 · FY2021 · DK · contact PI
UPMC Clinical Center for the Study of Diabetes After Acute Pancreatitis$275,548
U01 · FY2021 · DK · contact PI
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$90,650
U01 · FY2021 · DK · contact PI
SpHincterotomy for Acute Recurrent Pancreatitis$1,450,650
U01 · FY2020 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$469,495
U01 · FY2020 · DK · contact PI
UPMC Clinical Center for the Study of Diabetes After Acute Pancreatitis$273,726
U01 · FY2020 · DK · contact PI
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center$120,000
U01 · FY2020 · DK · contact PI
SpHincterotomy for Acute Recurrent Pancreatitis$1,399,189
U01 · FY2019 · DK
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center$397,778
U01 · FY2019 · DK · contact PI
Consortium for the Study of Chronic Pancreatitis: Pittsburgh Clinical Center$172,600
U01 · FY2019 · DK · contact PI
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer â Pittsburgh Clinical Center$112,657
U01 · FY2019 · DK · contact PI
SpHincterotomy for Acute Recurrent Pancreatitis$1,293,278
U01 · FY2018 · DK
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center$404,199
U01 · FY2018 · DK · contact PI
Consortium for the Study of Chronic Pancreatitis: Pittsburgh Clinical Center$109,320
U01 · FY2018 · DK · contact PI
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center$408,242
U01 · FY2017 · DK · contact PI
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center$410,472
U01 · FY2016 · DK · contact PI
Minor Endoscopic Sphincterotomy for Recurrent Acute Pancreatitis with Pancreas Divisum$350,614
U34 · FY2016 · DK
NAPS2-AS: Race Dependent Risk for Pancreatitis$583,517
R01 · FY2013 · DK · contact PI
NAPS2-AS: Race Dependent Risk for Pancreatitis$572,381
R01 · FY2012 · DK · contact PI
NAPS2-AS: Race Dependent Risk for Pancreatitis$517,683
R01 · FY2011 · DK · contact PI